SureTrader Advertisement PRTC
Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTB)

Add ENTB Price Alert      Hide Sticky   Hide Intro
Moderator: sizzleweed
Search This Board:
Last Post: 5/24/2016 2:46:21 PM - Followers: 449 - Board type: Free - Posts Today: 0






Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328

Web site:


CIK 0001449447

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)

Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.



David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance

 Recent News!

June 1, 2015




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ENTB News: Quarterly Report (10-q) 01/14/2016 12:11:12 PM
#37735   ENTB appears to be the ugly duckling of bucks2pennies 05/24/16 02:46:21 PM
#37734   I would think one of these days soon JokersWild12 05/20/16 01:34:45 AM
#37733   Maybe Elanco will show up sometime in the JokersWild12 05/03/16 03:45:37 PM
#37732   TO ALL...STOCKCHARTS REFUSES TO ADD RGBPP AND HAS gotinearly 04/26/16 01:46:46 PM
#37731   The Ferrari is at mid 40.85% throttle and Brakeman 04/22/16 07:26:50 AM
#37730   The big 4 are ready to rage. You sizzleweed 04/21/16 03:50:17 PM
#37729   Looks like one person grabbed 280k shares gotinearly 04/21/16 02:13:11 PM
#37728   Wonder why we have volume here suddenly? ctvette2003 04/21/16 01:37:24 PM
#37727   ENTB started at thread at RGBPP for the sizzleweed 04/21/16 01:58:21 AM
#37726   I figured that out a while back right jhenmal 04/13/16 11:02:02 PM
#37725   All these Koos stocks must not be in Brakeman 04/12/16 02:13:33 PM
#37724   ENTB. When? No news - FOR bucks2pennies 04/12/16 09:54:25 AM
#37723   The tCellvax IND submitted by Regen 3/23/16 mentions JokersWild12 04/05/16 11:41:38 AM
#37722   Up 47% and down 50%. Parsimonious MM'$ have sizzleweed 04/02/16 12:26:25 AM
#37721   ummm... up 47%? JustStartingOut 03/28/16 10:24:18 AM
#37720   What happened here? Brakeman 03/23/16 01:01:10 PM
#37719   Looks like .01 is prime loading zone! Never mind Lewisinhk 03/21/16 01:13:48 PM
#37718   Correct, swift like a speeding Ferrari ! Brakeman 03/21/16 10:35:09 AM
#37716   Entb will rip swift like a ferrari, smallest Lewisinhk 03/19/16 08:14:19 AM
#37714   ENTB up 122%. This is just the beginning. sizzleweed 03/09/16 05:53:25 PM
#37713   ENTB ready to pop. No one selling at sizzleweed 03/09/16 05:41:58 PM
#37712   ENTB has refined a cancer cure for animal sizzleweed 03/08/16 01:22:37 AM
#37711   ~ ENTB = I Luv da Science!! ;-) 1~Eye~Jack!! 03/06/16 06:02:23 PM
#37710   This news for Regen describes the approach of JokersWild12 03/06/16 05:23:04 PM
#37709   ~ ENTB = .000's Coming HerRre! :-( 1~Eye~Jack!! 03/06/16 12:53:35 PM
#37708   As you can see the best are on. prof81 02/29/16 10:40:43 PM
#37707   I agree, ENTB is like fruit ripening on sizzleweed 02/27/16 07:30:18 PM
#37706   Everyone needs to stick to a side. Stop prof81 02/25/16 01:39:37 PM
#37705   Sisters yes, here not a chance ctvette2003 02/24/16 09:10:35 PM
#37704   Major upswing about to happen to ENTB and prof81 02/24/16 07:48:19 AM
#37703   ENTB it is a matter of when, not sizzleweed 02/17/16 04:20:11 PM
#37702   Not dead just stagnant for now. Waiting on ctvette2003 02/14/16 01:51:02 PM
#37701   Been ENTB dead? cwbuff 02/12/16 01:26:12 PM
#37699   Any time, I am still learning about investing ctvette2003 01/14/16 02:58:43 PM
#37698   Thank you for that link ctvette. I didn't psk3091 01/14/16 02:51:43 PM
#37697 ctvette2003 01/14/16 02:45:09 PM
#37696   ctvette I realize that, but even fiscal would need psk3091 01/14/16 02:40:38 PM
#37695   Fiscal yr and not calendar yr. ctvette2003 01/14/16 02:15:17 PM
#37694   Since when does a Quarter end at the psk3091 01/14/16 01:43:34 PM
#37693   10q out. ronrooster 01/14/16 12:48:38 PM
#37692   I totally understand the cynicism and frustration with JokersWild12 01/08/16 10:32:07 AM
#37690   Emotions always have to be checked at the Brakeman 01/07/16 04:11:41 PM
#37689   Brakeman, with your Wharton School business degree, why Fitzgerald 01/07/16 03:13:45 PM
#37688   Thanks, but I will go with Dr. David sizzleweed 01/06/16 08:31:17 PM
#37687   Just using my Wharton school of business degree Brakeman 01/06/16 10:28:16 AM
#37686   Are you looking for pity? ENTB GM_FSJ 01/06/16 10:07:01 AM
#37685   When someone who talks up his business at Brakeman 01/06/16 09:11:05 AM
#37684   An oral for dogs, Palladia from Pfizer, has sizzleweed 01/05/16 04:24:34 PM
#37683   Interest in ENTB is increasing sharply. 2016 will sizzleweed 01/05/16 12:22:01 AM